-
Previously undiagnosed cancer is frequent in patients with an unprovoked VTE and is more often detected with an extensive cancer screening strategy than with a limited screening strategy.
-
A new agent has been approved by the fda for the treatment of thrombocytopenia associated with chronic immune thrombocytopenia purpura (ITP).
-
Terminally ill cancer patients who had end-of life discussions with their physician had better quality of life during their last week and their caregivers had an easier bereavement.
-
-
Ongoing safety review of tiotropium; raloxifene reduces the risk of endometrial cancer; one-day treatment with famciclovir may be as effective as 3-day treatment with valacyclovir; new Clinical Practice Guideline from the American College of Physicians regarding pharmacologic treatment for low bone density and osteoporosis; FDA Actions.
-
-
As infection prevention enters a new era of transparency, regulatory activity, and consumer activism, unprecedented demands are being placed on a profession that long labored in relative obscurity.
-
Sometimes you have to work fast to keep up with a new infection preventionist in career transition.
-
Concerns regarding patient safety have produced numerous pieces of new legislation focused on infection control surveillance and reporting of antibiotic-resistant organisms in healthcare facilities nationwide.
-
The Joint Commission has strongly endorsed recently issued compendium infection prevention guidelines, announcing that the condensed, actionable recommendations may become required as accreditation standards by 2010.